Compare · RXST vs WRBY
RXST vs WRBY
Side-by-side comparison of RxSight Inc. (RXST) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RXST and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- WRBY is the larger of the two at $3.21B, about 12.1x RXST ($266.2M).
- RXST has been more active in the news (5 items in the past 4 weeks vs 3 for WRBY).
- Both have 25 recent analyst ratings on file.
- Company
- RxSight Inc.
- Warby Parker Inc.
- Price
- -
- -
- Market cap
- $266.2M
- $3.21B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2021
- News (4w)
- 5
- 3
- Recent ratings
- 25
- 25
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest RXST
- Amendment: SEC Form SC TO-I/A filed by RxSight Inc.
- SEC Form SC TO-I filed by RxSight Inc.
- SEC Form 10-Q filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- SEC Form 4 filed by President and CEO Mottiwala Aziz
- SEC Form 3 filed by new insider Mottiwala Aziz
- SEC Form S-8 filed by RxSight Inc.
- RxSight Inc. filed SEC Form 8-K: Regulation FD Disclosure
Latest WRBY
- SEC Form 10-Q filed by Warby Parker Inc.
- Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Warby Parker Announces Second Quarter 2026 Results
- Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)